Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Jonathan Schoenfeld, MD, MPhil, MPH

Advertisement

Articles by Jonathan Schoenfeld, MD, MPhil, MPH

Jonathan Schoenfeld Answers: Which Patients Benefit Most from Immunotherapy and Radiation

ByJonathan Schoenfeld, MD, MPhil, MPH
October 28th 2016

Jonathan Schoenfeld discusses the patient profile that would benefit best from a combination of radiation and immunotherapy.

Advertisement

Latest Updated Articles

  • Jonathan Schoenfeld Answers: Which Patients Benefit Most from Immunotherapy and Radiation
    Jonathan Schoenfeld Answers: Which Patients Benefit Most from Immunotherapy and Radiation

    October 28th 2016



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Nurse-Led Strategies for Vitamin D in Cancer Care

2

How An Adaptive Weight-Loss Strategy Benefits Breast Cancer Survivors

3

Advances in Lymphoma Care: Experts Breakdown CAR T-Cell Therapy, Bispecifics, and CLL Management

4

Cancer Surgery Waiting Times Rising: What Oncology Nurses Need to Know

5

What Nurses Need to Know About FDA-Approved Iberdomide in Multiple Myeloma

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us